课题基金 / 基金详情

Alpha-2-Macroglobulin and the Transport and Uptake of the Hormone, Hepcidin

Alpha-2-Macroglobulin and the Transport and Uptake of the Hormone, Hepcidin
Alpha-2-巨球蛋白与激素铁调素的运输和摄取
批准号:
nhmrc : 632698
负责人:
Dr Yohan Suryo Rahmanto
金额:
$35.58万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2010
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2010-01-01 至 2012-12-31

项目摘要

项目成果

Dr Yohan Suryo Rahmanto的其他基金

相似基金

相关文献

中文摘要
翻译
海普西丁是一种多肽激素,是铁代谢的主要调节剂。已有研究表明,海普西丁在血液中是游离的。然而,我们最近发现,海普西丁与血浆中的α-2-巨球蛋白(a2-M)结合,这增加了这种多肽的疗效。A2-M在海普西丁生物学中的作用的证明将有助于更好地理解海普西丁的生理学,发展其测量方法,并改进铁相关疾病的治疗。
英文摘要
Hepcidin is a peptide hormone that is a major regulator of iron metabolism. It has been suggested that hepcidin is free in the blood. However, we recently identified that hepcidin binds with alpha-2-macroglobulin (a2-M) in the plasma and this increases the efficacy of this peptide. The demonstration that a2-M plays a role in hepcidin biology will lead to a better understanding of hepcidin physiology, the development of methods for its measurement and improved treatment of iron related diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Iron Complexes for the Treatment of FriedreichÍs Ataxia & the Role of Frataxin in Iron Metabolism
  • 批准号:
    nhmrc : 1002867
  • 项目类别:
    Project Grants
  • 资助金额:
    $41.08万
  • 财政年份:
    2011
  • 负责人:
    Dr Yohan Suryo Rahmanto
  • 依托单位:
The Role of Melanoma Tumour Antigen p97 (Melanotransferrin) in Melanoma Tumourigenesis.
  • 批准号:
    nhmrc : 570951
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $37.56万
  • 财政年份:
    2009
  • 负责人:
    Dr Yohan Suryo Rahmanto
  • 依托单位:
海外基金